Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer. - Wikidata - awgldk - TriplyDB

Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer.

Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q33400095

about

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer.Response of patients with locally advanced pancreatic adenocarcinoma to high-intensity focused ultrasound treatment: a single-center, prospective, case series in China

P2860

Q38104309-C2E08EE7-AF1F-4E80-BFBC-72E25BFA4E0B Q57816458-7CF56B15-9466-42E2-B5E2-1C09F2E40814

P2860

Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q33400095

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@ast

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@en

type

label

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@ast

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@en

prefLabel

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@ast

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@en

P1433

Q33400095-F5523AAD-21A3-40AB-83FD-44150944B244

P1476

Q33400095-8D0DE1EB-B424-43AA-B185-197520D30695

P2093

Q33400095-21273E65-1250-42ED-87D5-C959E5E1731A

Q33400095-3E272FA0-CA7C-4B9F-8EA7-F71A34D6B0C7

Q33400095-68F1FCB7-FF39-4B81-85B2-6EFFCD9F268B

Q33400095-7363F34F-0067-487D-91B6-87B245AACE0A

Q33400095-C1D9BFAF-3460-46DB-8C18-B21D683B968B

Q33400095-D5498BD0-8B63-4D51-9B07-35C599B61051

P2860

Q33400095-092D4DF1-BAB0-4A13-A80D-8F0BEEA3B419

Q33400095-14BE3714-114D-4A7B-9280-DCB28A77D4A4

Q33400095-21F5D3DE-36A0-4A99-BFFF-3FC3FC2DB3FE

Q33400095-271BEB6C-FED8-4B65-AD6F-83412CAD8A87

Q33400095-2C027A82-8D1A-4C6C-B818-06A95DCBA1FF

Q33400095-348F0DBD-517B-43AF-AA54-3E619C3A3D45

Q33400095-42127036-9726-4C5A-A6C7-35AE3087DE3D

Q33400095-4662CF37-F1C9-4043-960D-71051EE477FC

Q33400095-4DA365CC-D44F-4A09-AD0C-9D877D6A41C3

Q33400095-55CF4977-6661-42A6-B090-BD9FFF470E9F

P2888

Q33400095-3ABFC277-1D4A-4E75-8136-6EE94744C8A2

P304

Q33400095-1E16FB1C-1EEF-4523-A75B-05E32485FA3B

P31

Q33400095-A882926E-BA2F-4B8D-8082-AC8F920013F2

P356

Q33400095-FA239DFA-A58B-41B8-98F5-6A437F62867A

P433

Q33400095-690B5112-3E86-4919-8AB4-541735FBD9B4

P478

Q33400095-2FD7404C-C2E4-47D9-8B09-2D39CDF690A2

P577

Q33400095-9CD7D838-981F-4FCB-A8E9-993422104454

P5875

Q33400095-413457AF-5E00-45A0-9EB1-6BE896EC47F8

P6179

Q33400095-7425976C-9AE9-4743-AC2B-61D1BEC66E4D

P698

Q33400095-447438EA-0225-4089-B362-D6A43089EEF6

P356

S12032-012-0197-9

P1433

Medical Oncology

P1476

Sequential FOLFOX-6 and gemcit ...... metastatic pancreatic cancer.

@en

P2093

A Saroufim

http://www.w3.org/2001/XMLSchema#string

F Farhat

http://www.w3.org/2001/XMLSchema#string

F Nasr

http://www.w3.org/2001/XMLSchema#string

G Chahine

http://www.w3.org/2001/XMLSchema#string

J Kattan

http://www.w3.org/2001/XMLSchema#string

M Ghosn

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer.

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.

P2888

s12032-012-0197-9

P304

2831-2837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-012-0197-9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221889802

http://www.w3.org/2001/XMLSchema#string

P6179

1028084859

http://www.w3.org/2001/XMLSchema#string

P698

22392197

http://www.w3.org/2001/XMLSchema#string